JP2015524464A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015524464A5 JP2015524464A5 JP2015525915A JP2015525915A JP2015524464A5 JP 2015524464 A5 JP2015524464 A5 JP 2015524464A5 JP 2015525915 A JP2015525915 A JP 2015525915A JP 2015525915 A JP2015525915 A JP 2015525915A JP 2015524464 A5 JP2015524464 A5 JP 2015524464A5
- Authority
- JP
- Japan
- Prior art keywords
- blood component
- plasma
- growth factor
- gel
- supernatant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012503 blood component Substances 0.000 claims 6
- 239000003102 growth factor Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 2
- 230000004770 neurodegeneration Effects 0.000 claims 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 239000006228 supernatant Substances 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 208000015114 central nervous system disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 108010088880 plasmagel Proteins 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201200810A ES2442242B1 (es) | 2012-08-09 | 2012-08-09 | Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación. |
| ESP201200810 | 2012-08-09 | ||
| PCT/ES2013/000176 WO2014023860A1 (es) | 2012-08-09 | 2013-07-19 | Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015524464A JP2015524464A (ja) | 2015-08-24 |
| JP2015524464A5 true JP2015524464A5 (https=) | 2016-07-21 |
| JP6339568B2 JP6339568B2 (ja) | 2018-06-06 |
Family
ID=49111229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015525915A Expired - Fee Related JP6339568B2 (ja) | 2012-08-09 | 2013-07-19 | 神経変性障害の治療で使用するための血漿中の成長因子を含む組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20140044795A1 (https=) |
| EP (1) | EP2883569B1 (https=) |
| JP (1) | JP6339568B2 (https=) |
| KR (1) | KR102149162B1 (https=) |
| CN (1) | CN104519961A (https=) |
| AR (1) | AR092086A1 (https=) |
| BR (1) | BR112015002760A2 (https=) |
| CA (1) | CA2881075A1 (https=) |
| CL (1) | CL2014003510A1 (https=) |
| CO (1) | CO7170177A2 (https=) |
| ES (2) | ES2442242B1 (https=) |
| IN (1) | IN2014MN02675A (https=) |
| MX (1) | MX357828B (https=) |
| PE (1) | PE20150616A1 (https=) |
| RU (1) | RU2696497C2 (https=) |
| TW (1) | TWI649084B (https=) |
| WO (1) | WO2014023860A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2016003282A1 (es) | 2016-12-21 | 2017-08-18 | Univ Chile | Virus aav/igf2, método de tratamiento genético y su uso en enfermedades relacionadas con mal plegamiento de proteínas tal como la enfermedad de huntington |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2252993T3 (es) * | 1998-12-09 | 2006-05-16 | Chiron Corporation | Administracion de agentes neurotroficos al sistema nervioso central. |
| AR022333A1 (es) * | 1999-01-26 | 2002-09-04 | Anitua Aldecoa Eduardo | Regenerador de tejido oseo |
| US6811777B2 (en) * | 2002-04-13 | 2004-11-02 | Allan Mishra | Compositions and minimally invasive methods for treating incomplete connective tissue repair |
| US7608258B2 (en) * | 2002-04-13 | 2009-10-27 | Allan Mishra | Method for treatment of tendinosis using platelet rich plasma |
| ES2221770B2 (es) | 2002-04-19 | 2006-07-16 | Eduardo Anitua Aldecoa | Metodo de preparacion de un compuesto para la regeneracion de tejidos. |
| US20060004189A1 (en) * | 2004-07-02 | 2006-01-05 | James Gandy | Compositions for treating wounds and processes for their preparation |
| CA2620202C (en) * | 2005-08-26 | 2016-10-04 | The Board Of Trustees Of The Leland Stanford Junior University | Therapy procedure for drug delivery for trigeminal pain |
| EP2152240A4 (en) * | 2007-06-08 | 2012-05-09 | Healthpartners Res Foundation | PHARMACEUTICAL COMPOSITIONS AND METHOD FOR REINFORCED TARGETING OF THERAPEUTIC COMPOUNDS TO THE CENTRAL NERVOUS SYSTEM |
| ES2333498B1 (es) * | 2007-08-02 | 2011-01-10 | Biotechnology Institute, I Mas D, S.L. | Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto. |
| EP2212344B1 (en) * | 2007-09-14 | 2014-03-26 | Formycon AG | Use of slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases |
| MX2011011921A (es) | 2009-05-14 | 2011-12-06 | Biotechnology Inst I Mas D Sl | Metodo para la preparacion de al menos un compuesto a partir de sangre, y dispositivo de extraccion para ser utilizado en la ejecucion de dicho metodo. |
| KR101114712B1 (ko) * | 2009-10-23 | 2012-02-29 | 세원셀론텍(주) | 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(ｐｒｐ)을 활성화하여 조직재생을 유도하는 조성물의 제조방법 |
| ES2369945B1 (es) | 2011-07-29 | 2012-10-15 | Eduardo Anitua Aldecoa | Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento. |
-
2012
- 2012-08-09 ES ES201200810A patent/ES2442242B1/es not_active Expired - Fee Related
-
2013
- 2013-07-19 BR BR112015002760A patent/BR112015002760A2/pt not_active Application Discontinuation
- 2013-07-19 CA CA2881075A patent/CA2881075A1/en not_active Abandoned
- 2013-07-19 CN CN201380041280.4A patent/CN104519961A/zh active Pending
- 2013-07-19 RU RU2015104076A patent/RU2696497C2/ru active
- 2013-07-19 TW TW102125858A patent/TWI649084B/zh not_active IP Right Cessation
- 2013-07-19 WO PCT/ES2013/000176 patent/WO2014023860A1/es not_active Ceased
- 2013-07-19 JP JP2015525915A patent/JP6339568B2/ja not_active Expired - Fee Related
- 2013-07-19 MX MX2015001677A patent/MX357828B/es active IP Right Grant
- 2013-07-19 ES ES13756518.0T patent/ES2662385T3/es active Active
- 2013-07-19 KR KR1020157001551A patent/KR102149162B1/ko not_active Expired - Fee Related
- 2013-07-19 EP EP13756518.0A patent/EP2883569B1/en not_active Not-in-force
- 2013-07-19 PE PE2015000116A patent/PE20150616A1/es not_active Application Discontinuation
- 2013-08-08 US US13/962,340 patent/US20140044795A1/en not_active Abandoned
- 2013-08-08 AR ARP130102835A patent/AR092086A1/es unknown
-
2014
- 2014-12-23 CL CL2014003510A patent/CL2014003510A1/es unknown
- 2014-12-31 IN IN2675MUN2014 patent/IN2014MN02675A/en unknown
-
2015
- 2015-01-20 CO CO15010369A patent/CO7170177A2/es unknown
-
2016
- 2016-03-08 US US15/063,969 patent/US20160184360A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019502269A1 (en) | Quinazoline derivatives for the treatment of viral infections and further diseases | |
| JP2016515522A5 (https=) | ||
| ZA202004764B (en) | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof | |
| HK1207306A1 (en) | Modified polynucleotides for the production of proteins associated with human disease | |
| WO2013151666A3 (en) | Modified polynucleotides for the production of biologics and proteins associated with human disease | |
| MX2015005947A (es) | Formas de dosificacion de ruxolitinib de liberacion sostenida. | |
| EA201590343A1 (ru) | Алкилпиримидиновые производные для лечения вирусных инфекций и дальнейших заболеваний | |
| EA201291034A1 (ru) | АПТАМЕРЫ К β-NGF И ИХ ПРИМЕНЕНИЕ ПРИ ЛЕЧЕНИИ B-NGF-ОПОСРЕДОВАННЫХ ЗАБОЛЕВАНИЙ И РАССТРОЙСТВ | |
| EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
| CO6940374A2 (es) | Composiciones, usos y métodos para tratamiento de trastornos y enfermedades metabólicas | |
| EA201500365A1 (ru) | Комбинация регорафениба и ацетилсалициловой кислоты для лечения рака | |
| EA201300669A1 (ru) | Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение | |
| EA201891374A1 (ru) | Замещенные 2-фенил-3-(пиперазинметил)имидазопиридины и их применение | |
| EA201690246A1 (ru) | Ингибиторы аутотаксинов, содержащие ядро гетероароматическое кольцо-бензил-амидный цикл | |
| EA201590667A1 (ru) | Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний | |
| EP2797942A4 (en) | COMPOSITION OF NOVEL CARBOHYDRATE MEDICINE FOR THE TREATMENT OF HUMAN DISEASES | |
| EA201590520A1 (ru) | Фармацевтическая композиция с покрытием, содержащая регорафениб | |
| MX385898B (es) | Moleculas de fusion derivadas de la toxina colix para suministro oral de una carga biologicamente activa. | |
| ZA202105976B (en) | Pharmaceutical dosage form for application to mucous membranes and methods for producing same | |
| EA201500112A1 (ru) | 3-замещенные производные эстра-1,3,5(10),16-тетраена, способы их получения, фармацевтические средства, которые их содержат, и их использование для получения лекарственных средств | |
| MX2016006604A (es) | Derivados de piperidina con actividad multimodal contra el dolor. | |
| EP3285771A4 (en) | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa | |
| EA201591415A1 (ru) | Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии | |
| MX381932B (es) | Composicion intranasal que comprende betahistina. | |
| EA201592242A1 (ru) | Производные пиридона для лечения вирусных инфекций и других заболеваний |